Virtual Reality Cognitive Remediation for Psychosis
Trial Summary
The trial does not specify if you need to stop taking your current medications, but you must not have changed your medication dosage, started a new medication, or stopped a medication in the month before joining the trial.
Research shows that virtual reality (VR) therapy can help reduce avoidance and distress in people with psychosis, particularly those with severe symptoms. VR-based interventions have also been found to improve cognitive impairments and social skills in patients with psychosis.
12345The research does not provide specific safety data for Virtual Reality Cognitive Remediation, but it is generally considered acceptable and potentially effective for adults with psychosis.
46789The Virtual Reality Cognitive Remediation Program is unique because it uses fully immersive virtual reality tools to enhance cognitive function in people with psychosis, offering an engaging and interactive experience that traditional therapies may not provide. This approach aims to improve cognitive and functional abilities by simulating real-life scenarios, which can be more effective in helping patients apply cognitive skills to daily life.
4791011Eligibility Criteria
This trial is for people aged 20-55 with a psychosis-spectrum disorder like schizophrenia, who speak English and have had stable medication doses for the past month. It's not suitable for those with cognitive impairments from other conditions, no smartphone, seizure history, severe eye/ear/balance issues, significant brain injury, intellectual disability or recent substance abuse.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo a six-week cognitive remediation program using virtual reality, with exercises and discussions.
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments at 1-week and 3-months post-intervention.
Long-term Follow-up
Participants complete additional assessments at 6-months post-intervention to evaluate long-term effects.